Biotech by today's price change
How far the share price has moved since the previous close.
Twist Bioscience leads the 24 biotech ranked by today's price change, at +6.63%, ahead of ImmunityBio (+4.68%) and Adaptive Biotechnologies (+2.22%). Figures as of 18 Nov 2026, 14:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- Twist Bioscience+6.63%
- Median
- -0.35%
- Combined market value
- PLN 3.41T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Today ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Twist BioscienceTWST · Health Care | +6.63% | PLN 30.7B | PLN 450.02 | 6.63% up | 340% up | ||
| 2 | ImmunityBioIBRX · Health Care | +4.68% | PLN 26.8B | PLN 25.15 | 4.68% up | 193% up | ||
| 3 | Adaptive BiotechnologiesADPT · Health Care | +2.22% | PLN 18.5B | PLN 114.47 | 2.22% up | 88% up | ||
| 4 | ExelixisEXEL · Health Care | +2.09% | PLN 67.2B | PLN 275.24 | 2.09% up | 63% up | ||
| 5 | Gilead SciencesGILD · Health Care | +1.60% | PLN 848.5B | PLN 684.11 | 1.60% up | 33% up | ||
| 6 | Scholar Rock HoldingSRRK · Health Care | +1.21% | PLN 22.1B | PLN 181.13 | 1.21% up | 14% up | ||
| 7 | Neurocrine BiosciencesNBIX · Health Care | +0.37% | PLN 67.5B | PLN 666.67 | 0.37% up | 20% up | ||
| 8 | Krystal BiotechKRYS · Health Care | +0.22% | PLN 35.5B | PLN 1,199.58 | 0.22% up | 46% up | ||
| 9 | QiagenQGEN · Health Care | -0.12% | PLN 41.3B | PLN 199.90 | 0.12% down | 12% up | ||
| 10 | ImmunovantIMVT · Health Care | -0.21% | PLN 27.6B | PLN 133.44 | 0.21% down | 43% up | ||
| 11 | Bio-TechneTECH · Health Care | -0.22% | PLN 45.8B | PLN 291.83 | 0.22% down | 26% up | ||
| 12 | BiogenBIIB · Health Care | -0.34% | PLN 149B | PLN 1,007.68 | 0.34% down | 49% up | ||
| 13 | argenxARGX · Health Care | -0.36% | PLN 239.4B | PLN 3,807.16 | 0.36% down | 4% up | ||
| 14 | RepligenRGEN · Health Care | -0.37% | PLN 41.7B | PLN 651.64 | 0.37% down | 5% up | ||
| 15 | BioNTechBNTX · Health Care | -0.47% | PLN 84.5B | PLN 340.97 | 0.47% down | 16% down | ||
| 16 | CRISPR TherapeuticsCRSP · Health Care | -0.54% | PLN 15.6B | PLN 161.32 | 0.54% down | 21% down | ||
| 17 | Halozyme TherapeuticsHALO · Health Care | -0.55% | PLN 44B | PLN 385.61 | 0.55% down | 37% up | ||
| 18 | AmgenAMGN · Health Care | -0.95% | PLN 995.3B | PLN 1,839.98 | 0.95% down | 34% up | ||
| 19 | Revolution MedicinesRVMD · Health Care | -2.50% | PLN 141.4B | PLN 653.69 | 2.50% down | 131% up | ||
| 20 | Kymera TherapeuticsKYMR · Health Care | -3.44% | PLN 41.7B | PLN 488.27 | 3.44% down | 87% up | ||
| 21 | VaxcytePCVX · Health Care | -3.59% | PLN 37.8B | PLN 238.67 | 3.59% down | 22% up | ||
| 22 | Kodiak SciencesKOD · Health Care | -3.90% | PLN 25.4B | PLN 388.95 | 3.90% down | 396% up | ||
| 23 | ModernaMRNA · Health Care | -3.93% | PLN 336.2B | PLN 830.93 | 3.93% down | 755% up | ||
| 24 | CG OncologyCGON · Health Care | -6.89% | PLN 28.3B | PLN 317.18 | 6.89% down | 85% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0180 PLN).
Questions and answers
Which biotech rank first by today's price change?
Twist Bioscience (+6.63%), ImmunityBio (+4.68%) and Adaptive Biotechnologies (+2.22%) are the top three of the 24 biotech ranked by today's price change as of 18 Nov 2026, 14:08 UTC.
How many biotech are in this ranking?
24 are ranked by today's price change.
What are these biotech worth together?
The 24 biotech ranked by today's price change have a combined market value of PLN 3.41T as of 18 Nov 2026, 14:08 UTC.
What does ranking by today's price change measure?
How far the share price has moved since the previous close.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change
Underlying data: Yahoo Finance; SEC EDGAR.